Victory Capital Management Inc Mustang Bio, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$2.33 - $4.6 $11,787 - $23,271	-5,059 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$1.91 - $4.52 $219 - $519	-115 Reduced 2.22%	5,059 $14,000
Q4 2019 Feb 04, 2020	SELL	$2.57 - $4.08 $115 - $183	-45 Reduced 0.86%	5,174 $19,000
Q3 2019 Nov 12, 2019	BUY	$2.74 - $4.65 $14,300 - $24,268	5,219 New	5,219 $17,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $35.8M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.